Krsnaa Diagnostics Limited logo

KRSNAA

NSE
Krsnaa Diagnostics Limited (SMALL CAP)
Healthcare>Healthcare>Healthcare Services>Healthcare Service Provider
556.65
0.25 (0.04%)
High VOLATILITY
As on 10 Jul 2026

Price History

Market Cap
₹1.81K Cr
SMALL CAP
P/E Ratio
17.8
Industry
Healthcare Service Provider
52-Week Range
52W Low515+8.1%
52W High894.4-37.8%
Current Price
556.65
Circuit Limits (20%)
Lower Circuit445.32
Upper Circuit667.98
Reference Price
556.65

Investment Checklist

Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹537.9
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹528.25
Volume divergence: Bearish (price up, volume down)
Composite score -37.62 (SELL) with 49.2% confidence
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))

Technical Analysis

Technical Analysis

Analysis from 2026-07-10

Confidence
49%

Trend

NEUTRAL
NEUTRAL

Mixed MA signals — sideways/transition | Bearish MA stack (20<50<200)

EMA20
549.02
EMA50
558.17
EMA200
657.23

Price Action

UPTREND
BULLISH
Higher Highs6
Higher Lows7
Lower Highs3
Lower Lows2

Support & Resistance Levels

Resistance (Above)
558.55
578.85
621.18
630.35
654.25
Support (Below)
530.67
515.00

Volume Analysis

TrendDECREASING
Change-16.10%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)

Stop Loss Levels

Fixed Risk

1% Risk551.08
3% Risk539.95
5% Risk528.82
7% Risk (Custom)
517.68

Technical Levels

1x ATR (Volatility)540.23
2x ATR (Swing)523.81
3x ATR (Trend)507.39
Immediate Support530.67

Moving Averages

EMA 9 (Short-term)551.98
EMA 20 (Medium-term)549.02

Financials

Financial Analysis

MetricMar '25Jun '25Sep '25Dec '25
Revenue₹186.1 Cr₹193 Cr₹206 Cr₹181.2 Cr
Net Profit₹20.7 Cr₹20.5 Cr₹23.9 Cr₹15.2 Cr
EPS₹6.35₹7.38₹4.72
Operating Profit₹54.5 Cr₹55.4 Cr₹63.3 Cr₹50.1 Cr
ROE
8.79%
ROCE
11.46%
Debt/Equity
0.23
Current Ratio
1.36
OPM
27.66%
NPM
8.41%

Peer Comparison

Healthcare Service Provider

Peer Comparison

Symbol
Name
Price
Change
P/E Ratio
Market Cap
Dr. Lal Path Labs Ltd.₹1,692.80+0.49%55.4
₹28.36K Cr
Vijaya Diagnostic Centre Limited₹1,389.10+0.82%82.0
₹14.29K Cr
Thyrocare Technologies Limited₹515.70-3.71%52.8
₹8.21K Cr
Nephrocare Health Services Limited₹649.00+2.46%
₹6.51K Cr
Metropolis Healthcare Limited₹567.95+1.41%60.7
₹2.94K Cr
Krsnaa Diagnostics Limited₹556.65-0.04%17.8
₹1.81K Cr
Suraksha Diagnostic Limited₹264.30+0.34%43.7
₹1.38K Cr
Health X Platform Limited₹323.30-1.93%34.1
₹1.03K Cr
3B Blackbio Dx Limited₹1,148.60-1.64%
₹986 Cr
Chandan Healthcare Limited₹249.65-1.75%21.8
₹610 Cr
Invicta Diagnostic Limited₹69.00-0.58%
₹87 Cr

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All
Ex DatePurposeType
12 Sept 2025
Dividend - Rs 2.75 Per Share
DIVIDEND
13 Sept 2024
Dividend - Rs 2.50 Per Share
DIVIDEND
13 Sept 2024
Annual General Meeting
AGM
15 Sept 2023
Annual General Meeting
AGM
15 Sept 2023
Dividend - Rs 2.75 Per Share
DIVIDEND

Announcements

Latest updates

View All
DateDescriptionLink
09 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
07 Jul 2026
Shareholders meeting
29 Jun 2026
Credit Rating
25 Jun 2026
Trading Window
22 Jun 2026
Disclosure under SEBI Takeover Regulations

Board Meetings

Upcoming and past meetings

View All
DatePurposeLinks
25 May 2026
Financial Results/Dividend
25 May 2026
Board Meeting Intimation
05 Feb 2026
Board Meeting Intimation
05 Feb 2026
Financial Results
12 Dec 2025
Fund Raising

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for KRSNAA

View All
NEWS
positive
Business Standard - Markets 45d ago

Krsnaa Diagnostics Q4 PAT climbs 102% YoY to Rs 42 cr

Krsnaa Diagnostics reported a 101.74% increase in consolidated net profit to Rs 41.72 crore in Q4 FY26 from Rs 20.68 crore posted in Q4 FY25.

KRSNAAHealthcare
NEWS
positive
Business Standard - Markets 46d ago

Krsnaa Diagnostics consolidated net profit rises 101.74% in the March 2026 quarter

Sales rise 3.50% to Rs 192.60 crore

KRSNAAHealthcare
Krsnaa Diagnostics follows a dual-engine growth strategy
positive
Moneycontrol NaNd ago

Krsnaa Diagnostics follows a dual-engine growth strategy

PPP leadership and retail expansion strengthen the outlook

KRSNAARETAILSDREAMSV2RETAILConsumer ServicesHealthcare

Frequently Asked Questions